MGMT and PTEN as potential prognostic markers in breast cancer (2012)
Source: Experimental and Molecular Pathology. Unidade: FO
Subjects: NEOPLASIAS, PROGNÓSTICO, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO, J. C et al. MGMT and PTEN as potential prognostic markers in breast cancer. Experimental and Molecular Pathology, v. 92, n. 1, p. 20-26, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.yexmp.2011.09.019. Acesso em: 09 maio 2024.APA
Neto, J. C., Ikoma, M. M., Carvalho, K. C., Vassallo, J., De Brot, M., Gobbi, H., et al. (2012). MGMT and PTEN as potential prognostic markers in breast cancer. Experimental and Molecular Pathology, 92( 1), 20-26. doi:10.1016/j.yexmp.2011.09.019NLM
Neto JC, Ikoma MM, Carvalho KC, Vassallo J, De Brot M, Gobbi H, Soares FA, Rocha RM. MGMT and PTEN as potential prognostic markers in breast cancer [Internet]. Experimental and Molecular Pathology. 2012 ; 92( 1): 20-26.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.yexmp.2011.09.019Vancouver
Neto JC, Ikoma MM, Carvalho KC, Vassallo J, De Brot M, Gobbi H, Soares FA, Rocha RM. MGMT and PTEN as potential prognostic markers in breast cancer [Internet]. Experimental and Molecular Pathology. 2012 ; 92( 1): 20-26.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.yexmp.2011.09.019
